Masimo Analysts Cut Their Forecasts Following Preliminary Q2 Results

Masimo Corporation MASI reported weak preliminary revenue results for the second quarter.

For the second quarter, the company expects revenues of $453 million- $457 million range (consensus: $553.23 million). The healthcare revenue is expected to be $280 million-$282 million range, and non-healthcare revenue is projected to range $173 million-$175 million.

For 2023, Masimo expects to reduce the lower end of revenue guidance for the healthcare business to $1.30 billion (from $1.45 billion earlier) and projects to decrease revenue guidance for the non-healthcare business to $800 million-$850 million (from $965 million-$995 million guided earlier).

Masimo shares dipped 28% to $106.00 in pre-market trading.

These analysts made changes to their price targets on Masimo following earnings announcement.

  • Stifel cut the price target on Masimo from $205 to $120. Stifel analyst Rick Wise downgraded the stock from Buy to Hold.
  • Needham slashed the price target on Masimo from $207 to $136. Needham analyst Mike Matson maintained a Buy rating.

 

Check This Out: Bank of America, Morgan Stanley And 3 Stocks To Watch Heading Into Tuesday

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: EarningsNewsGuidancePrice TargetPre-Market OutlookMarketsAnalyst RatingsTrading IdeasPreliminary ResultsPT Changes
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!